RRM2 and non-small cell lung carcinoma: Huang and colleagues studied 44 patient samples and found that the overexpression of RRM2 promoted proliferation, inhibited apoptosis, and increased the chemotherapy resistance of NSCLC cells through upregulating EGFR expression and AKT phosphorylation 17.